The global healthcare industry is increasingly focusing on rare disease management and advanced hematology treatments, creating strong growth opportunities for the acquired hemophilia treatment market. Acquired hemophilia is a rare autoimmune bleeding disorder caused by the development of autoantibodies against clotting factors, particularly factor VIII. The condition can lead to severe...